AIDS, Avian flu, SARS, MERS, Ebola, Zika… what next? (Q38158662)

29 August 2017

1 reference

title

AIDS, Avian flu, SARS, MERS, Ebola, Zika… what next? (English)

1 reference

29 August 2017

0 references

Orthoebolavirus zairense

0 references

0 references

0 references

1 reference

2

Albert D M E Osterhaus

1 reference

29 August 2017

Leslie A Reperant

1

1 reference

29 August 2017

language of work or name

English

0 references

publication date

17 June 2017

1 reference

29 August 2017

number of pages

5

1 reference

inferred from page(s)

published in

Vaccine

1 reference

29 August 2017

volume

35

1 reference

29 August 2017

issue

35 Pt A

1 reference

29 August 2017

page(s)

4470-4474

1 reference

on focus list of Wikimedia project

29 August 2017

WikiProject Zika Corpus

0 references

cites work

The Anthropocene is functionally and stratigraphically distinct from the Holocene

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2017.04.082

Rinderpest eradication: lessons for measles eradication?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2017.04.082

Origin of HIV-1 in the chimpanzee Pan troglodytes troglodytes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2017.04.082

Isolation of a T-Lymphotropic Retrovirus from a Patient at Risk for Acquired Immune Deficiency Syndrome (AIDS)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2017.04.082

The CD4 (T4) antigen is an essential component of the receptor for the AIDS retrovirus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2017.04.082

Ad26/MVA therapeutic vaccination with TLR7 stimulation in SIV-infected rhesus monkeys

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2017.04.082

Adaptive pathways of zoonotic influenza viruses: from exposure to establishment in humans

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2017.04.082

Estimated global mortality associated with the first 12 months of 2009 pandemic influenza A H1N1 virus circulation: a modelling study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2017.04.082

Advances in influenza vaccination.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2017.04.082

Cross-reactive antibody responses to the 2009 pandemic H1N1 influenza virus.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2017.04.082

Trial of 2009 influenza A (H1N1) monovalent MF59-adjuvanted vaccine.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2017.04.082

Response to a monovalent 2009 influenza A (H1N1) vaccine.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2017.04.082

Serologic survey of pandemic (H1N1) 2009 virus, Guangxi Province, China

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2017.04.082

Safety and immunogenicity of 2009 pandemic influenza A H1N1 vaccines in China: a multicentre, double-blind, randomised, placebo-controlled trial.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2017.04.082

Filoviridae: a taxonomic home for Marburg and Ebola viruses?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2017.04.082

Filoviruses in bats: current knowledge and future directions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2017.04.082

Fighting Ebola: A Window for Vaccine Re-evaluation?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2017.04.082

The severe acute respiratory syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2017.04.082

Identification of a novel coronavirus in patients with severe acute respiratory syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2017.04.082

Aetiology: Koch's postulates fulfilled for SARS virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2017.04.082

Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2017.04.082

Cross-host evolution of severe acute respiratory syndrome coronavirus in palm civet and human

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2017.04.082

Bats are natural reservoirs of SARS-like coronaviruses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2017.04.082

Pegylated interferon-alpha protects type 1 pneumocytes against SARS coronavirus infection in macaques

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2017.04.082

A SARS DNA vaccine induces neutralizing antibody and cellular immune responses in healthy adults in a Phase I clinical trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2017.04.082

Isolation of a novel coronavirus from a man with pneumonia in Saudi Arabia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2017.04.082

Dipeptidyl peptidase 4 is a functional receptor for the emerging human coronavirus-EMC

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2017.04.082

Bat origins of MERS-CoV supported by bat coronavirus HKU4 usage of human receptor CD26

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2017.04.082

An orthopoxvirus-based vaccine reduces virus excretion after MERS-CoV infection in dromedary camels

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2017.04.082

Status of research and development of vaccines for chikungunya

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2017.04.082

Zika virus outside Africa

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2017.04.082

Zika Virus as a Cause of Neurologic Disorders

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2017.04.082

Development of a Zika vaccine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2017.04.082

Diseases of humans and their domestic mammals: pathogen characteristics, host range and the risk of emergence

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2017.04.082

A randomized controlled trial of interventions to impede date palm sap contamination by bats to prevent nipah virus transmission in Bangladesh

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2017.04.082

The epidemiological transition: the current status of infectious diseases in the developed world versus the developing world

7 January 2021

1 reference

12 December 2020

Safety and immunogenicity from a phase I trial of inactivated severe acute respiratory syndrome coronavirus vaccine

1 reference

12 December 2020

One health: the Hong Kong experience with avian influenza

1 reference

12 December 2020

The importance of understanding the human-animal interface : from early hominins to global citizens

1 reference

12 December 2020

10.1016/J.VACCINE.2017.04.082

Identifiers

DOI

1 reference

release_ofks7hkzi5erpbsgxs775jbbim

29 August 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/ofks7hkzi5erpbsgxs775jbbim

24 November 2022

mapped directly with Wikidata item

1 reference

https://api.fatcat.wiki/v0/release/ofks7hkzi5erpbsgxs775jbbim

24 November 2022

mapped directly with Wikidata item

1 reference